期刊文献+

北京肿瘤医院2003年护肝类药物应用频度分析 被引量:7

Analysis of application frequency of liver protective drugs used in Beijing cancer hospital during 2003
下载PDF
导出
摘要 目的:了解我院2003年护肝类药物的应 用情况及合理用药水平。方法:对我院2003年护肝 类药物的用药频度、用药金额及其排序等统计数据 进行分析。结果:谷胱甘肽注射剂的用药频度和销 售金额均为首位,国产药品的用药频度和销售金额 的百分比分别为87.53%和70.60%。结论:谷胱 甘肽注射剂为我院护肝类药物之首选,国产药品的 应用占主导地位。多数药物的金额/用药频度序号 比的比值接近1.0,我院该类药物的费用基本合理。 AIM:To comprehend the using situation and the level of rational usage of liver protective drugs in our hospital during 2003. METHODS:The liver protective drugs used in our hospital during 2003 were analyzed by using the methods of DDDs order and amount of money for medication. RESULTS:Both the DDDs and the total money of the reduced glutathione for injection were shown as number one.The DDDs and the value sold of the domestic products were 87.53 % and 70.60 %, respectively. CONCLUSION:Glutathione for injection should be the first choice of the liver protective drug,mainly of domestic products.The value of ratio between the drug price and DDDs for most of these drugs approximotely equaled to one.The costs of these kinds of medicines were reasonable as a whole.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2005年第2期131-133,共3页 Chinese Journal of New Drugs and Clinical Remedies
关键词 谷胱甘肽 药物疗法 药物利用评审 glutathione drug therapy drug utilization review
  • 相关文献

参考文献4

二级参考文献34

  • 1匿名著者,中华传染病杂志,1995年,13卷,241页
  • 2郑芝田,胃肠病学,1993年,776页
  • 3Weijl NI,Cleton FJ,Osanto S. Free radicals and antioxidants in chemotherapy-induced toxicity [J]. Cancer Treat Rev,1997,23:209- 240.
  • 4Paolicchi A,Pompella A,Tonarelli P,et al. Gamma-glutamyltranspeptidase activity in human ovarian carcinoma [J]. Anticancer Res,1996,16(5B):3053- 3058.
  • 5Meister A. Glutathione metabolism and its selective modification [J]. J Biol Chem,1988,263:17205- 17208.
  • 6Schmidinger M,Budinsky AC,Wenzel C,et al. Glutathione in the prevention of cisplatin induced toxicities. A prospectively randomized pilot trial in patients with head and neck cancer and non small cell lung cancer [J]. Wien Klin Wochenschr,2000,112(14):617- 623.
  • 7Zunino F,Pratesi G,Micheloni A,et al. Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug [J]. Chem Biol Interact,1989,70(1- 2):89- 101.
  • 8Barranco SC,Weintraub B,MacLean KK,et al. Relationship between glutathione levels and drug or radiation sensitivities in human gastric cancer cell lines in vitro [J]. Invest New Drugs,1991,9(1):29- 36.
  • 9Lewandowicz GM,Britt P,Elgie AW,et al. Cellular glutathione content, in vitro chemoresponse, and the effect of BSO modulation in samples derived from patients with advanced ovarian cancer [J]. Gynecol Oncol,2002,85(2):298- 304.
  • 10Perquin M,Oster T,Maul A,et al. The glutathione-related detoxification system is increased in human breast cancer in correlation with clinical and histopathological features [J]. J Cancer Res Clin Oncol,2001,127(6):368- 374.

共引文献67

同被引文献21

引证文献7

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部